| DAIC

Medical device developer Cardionomic Inc. announced that it has received $20 million in Series A financing. Investors include New Enterprise Associates (NEA), the Cleveland Clinic, Greatbatch Inc. and others.

Read more about Cardionomic Raises $20 Million to Develop Neuromodulation for Heart Failure

Read more about Cardionomic

Miracor Medical Systems GmbH announced that its PiCSO system was highlighted during the 2015 Transcatheter Cardiovascular Therapeutics (TCT) conference in San as offering new hope for cardioprotection during percutaneous coronary intervention (PCI).

Read more about Miracor’s PiCSO Impulse System Highlighted at TCT 2015

Access Scientific LLC announced validation of the Powerwand midline IV catheter for power-injectable capability up to 8ml/sec, 325 psi for up to 10 cycles. The addition of this performance capability makes both 4Fr and 5Fr Powerwands ideal for virtually all computed tomography (CT) contrast studies, to meet the most demanding injection protocols.

Read more about Access Scientific Powerwand Validated for CT Contrast Injection

Adventist Medical Center in Portland, Ore., is known for its new, state-of-the-art Northwest Regional Heart and Vascular facility. Serving residents of the greater Portland-Vancouver metropolitan area, Adventist is one of only three accredited chest pain centers in the state. Consumer Reports calls it “one of the safest hospitals in the nation for clinical outcomes.” Staff and clinicians in the cardiovascular service line work continuously to improve the already excellent standard of care delivered at Adventist.

Read more about Adventist Medical Center Introduces Analytics to Accelerate Custom Reporting, Improve Door-to-ECG Time

The American College of Cardiology, the American Heart Association and The Society of Thoracic Surgeons released a new statement in early October on the future of clinical registries titled ACC/AHA/STS Statement on the Future of Registries and the Performance Measurement Enterprise.

Read more about Societies Release Statement on the Future of Clinical Registries

Boston Scientific Corp. has received CE Mark on magnetic resonance imaging (MRI) conditional labeling for the current family of EL (Extended Longevity) and Mini implantable cardioverter defibrillator (ICD) and the X4 cardiac resynchronization therapy defibrillator (CRT-D) systems. This revised labeling ensures that future patients and those already implanted with these systems are able to undergo MRI scans if indicated.